Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14684-5 Creatinine SRat Urine 24H Qn     ACTIVE Creatinine [Moles/time] in 24 hour Urine   MIN DefinitionDescription     mmol/24 H             CHEM   14684-5         Both       0 Creat 24h Ur-sRate       Y   1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Kidney; Nephrology; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UCr; UR; Urn 2.73 1.0k               mmol/(24.h)       0
14685-2 Cobalamins SCnc Ser/Plas Pt Qn     ACTIVE Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     pmol/L;nmol/L             CHEM   14685-2         Both       0 Vit B12 SerPl-sCnc       Y   C721; Cbl; Chemistry; Cobalamin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B12; Vitamin B12 2.73 1.0k               pmol/L       0
14686-0 Cystine PrThr Calculus Pt Ord     ACTIVE Cystine [Presence] in Stone   MIN DefinitionDescription                   CHEM   14686-0         Observation       0 Cystine Stone Ql           Calc; Calculi; Chemistry; Cys-Cys; Dicysteine; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones 2.56 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14687-8 Transfusion date TmStp ^Patient Pt Qn     ACTIVE Transfusion date   MIN DefinitionDescription                   BLDBK   14687-8         Observation       0 Transf Date       Y   BLOOD BANK; Date and time; date transfused; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; Transf Date; Tx 2.26 1.0k                       0
14688-6 Dehydroepiandrosterone sulfate SCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             CHEM   14688-6         Both       0 DHEA-S SerPl-sCnc       Y   adrenal dysfunction; Chemistry; DHEA; DHEAS; DHEA-S; DHEA-SO4; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; Prasterone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Substance concentration; Sulf 2.73 1.0k               umol/L       0
14689-4 Delta aminolevulinate SRat Urine 24H Qn     ACTIVE Delta aminolevulinate [Moles/time] in 24 hour Urine   MIN DefinitionDescription     umol/24 H             CHEM   14689-4         Both       0 D-ALA 24h Ur-sRate       Y   1 day; 24 hours; 24HR; 5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; D-ALA; Delta-ala; Delta-aminolevulinic acid; Hematology; Heme; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.73 1.0k               umol/(24.h)       0
1469-6 Follitropin^15M post 100 ug luteinizing releasing hormone IV MCnc Ser/Plas Pt Qn     DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV   NAM DefinitionDescription     ng/mL             CHAL   1469-6         Observation       0 FSH 15M p 100 ug LRH IV SerPl-mCnc       Y   15M p 100 ug LRH IV; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14690-2 N-desalkylflurazepam SCnc Ser/Plas Pt Qn     ACTIVE N-desalkylflurazepam [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14690-2         Both       0 Desalkylfluraz SerPl-sCnc       Y   Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; norfludiazepam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               umol/L       0
14691-0 Desipramine SCnc Ser/Plas Pt Qn     ACTIVE Desipramine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14691-0         Both       0 Desipramine SerPl-sCnc       Y   Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipramine metabolite; Level; Norpramin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14692-8 Desipramine SCnc Urine Pt Qn     ACTIVE Desipramine [Moles/volume] in Urine   MIN DefinitionDescription     nmol/L             DRUG/TOX   14692-8         Both       0 Desipramine Ur-sCnc       Y   Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipramine metabolite; Level; Norpramin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.42 1.0k               nmol/L       0
14693-6 Norclobazam SCnc Ser/Plas Pt Qn     ACTIVE Norclobazam [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14693-6         Both       0 Norclobazam SerPl-sCnc       Y   Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Level; N-desmethylclobazam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14694-4 Norclomipramine SCnc Ser/Plas Pt Qn     ACTIVE Norclomipramine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   14694-4         Both       0 Norclomipramine SerPl-sCnc       Y   Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               nmol/L       0
14695-1 Nordoxepin SCnc Ser/Plas Pt Qn     ACTIVE Nordoxepin [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14695-1         Both       0 Nordoxepin SerPl-sCnc       Y   Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Doxepin metabolite; DRUG/TOXICOLOGY; Drugs; Level; N-desmethyldoxepin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14696-9 Deuteroporphyrin SCnc Stool Pt Qn     ACTIVE Deuteroporphyrin [Moles/volume] in Stool   MIN DefinitionDescription     nmol/L             CHEM   14696-9         Observation       0 Deuteropor Stl-sCnc       Y   Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration 2.42 1.0k               nmol/L       0
14697-7 diazePAM SCnc Ser/Plas Pt Qn     ACTIVE diazePAM [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14697-7         Both       0 diazePAM SerPl-sCnc       Y   Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stesolid; Substance concentration; Valium 2.34 1.0k               umol/L       0
14698-5 Digoxin SCnc Ser/Plas Pt Qn     ACTIVE Digoxin [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   14698-5         Both       0 Digoxin SerPl-sCnc       Y   Cardio; Cardiology; DGXN; DRUG/TOXICOLOGY; Drugs; Heart Disease; Lanoxin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               nmol/L       0
14699-3 diphenhydrAMINE+dimenhyDRINATE PrThr Gast fld Pt Ord     ACTIVE diphenhydrAMINE+dimenhyDRINATE [Presence] in Gastric fluid   MIN DefinitionDescription                   DRUG/TOX   14699-3         Both       0 Diphenhyd+Dimenhyd Gast Ql           Benadryl; Diphenhyd+Dimenhyd; Diphenhydr; Diphenylhydramine; Dramamine; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.69 1.0k                     Release 2.69: COMPONENT: Added TALLMAN lettering to dimenhyDRINATE; Previous Releases: The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
147-9 Cefuroxime.parenteral Titr Isolate+Ser Pt SemiQn SBT   ACTIVE Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer   MAJ DefinitionDescription     titer             ABXBACT   147-9   SBT     Observation       0 Cefuroxime Parenter Titr SBT           ANTIBIOTIC SUSCEPTIBILITIES; c308; C33; Ceftin; Cefuroxime Axetil; Cefuroxime Parenter; Cefuroxime Sodium; Curoxim; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefurox; Point in time; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr; Ultroxim; Zinacef 2.75 1               {titer}       0
1470-4 Follitropin^1H post 100 ug luteinizing releasing hormone IV MCnc Ser/Plas Pt Qn     DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --1 hour post 100 ug luteinizing releasing hormone IV   NAM DefinitionDescription     ng/mL             CHAL   1470-4         Observation       0 FSH 1h p 100 ug LRH IV SerPl-mCnc       Y   1 hour; 1.0Hr; 1h p 100 ug LRH IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14700-9 diphenhydrAMINE+dimenhyDRINATE PrThr Ser/Plas Pt Ord     ACTIVE diphenhydrAMINE+dimenhyDRINATE [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   14700-9         Both       0 Diphenhyd+Dimenhyd SerPl Ql           Benadryl; Diphenhyd+Dimenhyd; Diphenhydr; Diphenylhydramine; Dramamine; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1.0k                     Release 2.69: COMPONENT: Added TALLMAN lettering to dimenhyDRINATE; Previous Releases: The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14701-7 diphenhydrAMINE+dimenhyDRINATE PrThr Urine Pt Ord     ACTIVE diphenhydrAMINE+dimenhyDRINATE [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   14701-7         Both       0 Diphenhyd+Dimenhyd Ur Ql           Benadryl; Diphenhyd+Dimenhyd; Diphenhydr; Diphenylhydramine; Dramamine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0k                     Release 2.69: COMPONENT: Added TALLMAN lettering to dimenhyDRINATE; Previous Releases: The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14702-5 Disopyramide SCnc Ser/Plas Pt Qn     ACTIVE Disopyramide [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14702-5         Both       0 Disopyramide SerPl-sCnc       Y   Diso durules; DRUG/TOXICOLOGY; Drugs; Level; Norpace; Pl; Plasma; Plsm; Point in time; Pyramide; QNT; Quan; Quant; Quantitative; Random; Rythmodan; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14703-3 DOPamine SCnc Ser/Plas Pt Qn     ACTIVE DOPamine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             CHEM   14703-3         Both       0 DOPamine SerPl-sCnc       Y   Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               nmol/L       0
14704-1 Doxepin PrThr Gast fld Pt Ord     ACTIVE Doxepin [Presence] in Gastric fluid   MIN DefinitionDescription                   DRUG/TOX   14704-1         Both       0 Doxepin Gast Ql           Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sinequan 2.56 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14705-8 Doxepin SCnc Ser/Plas Pt Qn     ACTIVE Doxepin [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14705-8         Both       0 Doxepin SerPl-sCnc       Y   Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinequan; SR; Substance concentration 2.73 1.0k               umol/L       0
104,672 results found